Literature DB >> 20473912

De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one.

Ajay Goel1, Thuy-Phuong Nguyen, Hon-Chiu E Leung, Takeshi Nagasaka, Jennifer Rhees, Erin Hotchkiss, Mildred Arnold, Pia Banerji, Minoru Koi, Chau-To Kwok, Deborah Packham, Lara Lipton, C Richard Boland, Robyn L Ward, Megan P Hitchins.   

Abstract

Lynch syndrome is an autosomal dominant cancer predisposition syndrome classically caused by germline mutations of the mismatch repair genes, MLH1, MSH2, MSH6 and PMS2. Constitutional epimutations of the MLH1 gene, characterized by soma-wide methylation of a single allele of the promoter and allelic transcriptional silencing, have been identified in a subset of Lynch syndrome cases lacking a sequence mutation in MLH1. We report two individuals with no family history of colorectal cancer who developed that disease at age 18 and 20 years. In both cases, cancer had arisen because of the de novo occurrence of a constitutional MLH1 epimutation and somatic loss-of-heterozygosity of the functional allele in the tumors. We show for the first time that the epimutation in one case arose on the paternally inherited allele. Analysis of 13 tumors from seven individuals with constitutional MLH1 epimutations showed eight tumors had lost the second MLH1 allele, two tumors had a novel pathogenic missense mutation and three had retained heterozygosity. Only 1 of 12 tumors demonstrated the BRAF V600E mutation and 3 of 11 tumors harbored a mutation in KRAS. The finding that epimutations can originate on the paternal allele provides important new insights into the mechanism of origin of epimutations. It is clear that the second hit in MLH1 epimutation-associated tumors typically has a genetic not epigenetic basis. Individuals with mismatch repair-deficient cancers without the BRAF V600E mutation are candidates for germline screening for sequence or methylation changes in MLH1.
Copyright © 2010 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20473912      PMCID: PMC3794437          DOI: 10.1002/ijc.25422

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  39 in total

1.  Sex determination by PCR analysis of the X-Y amelogenin gene.

Authors:  A Akane
Journal:  Methods Mol Biol       Date:  1998

2.  Tumorigenesis in colorectal tumors from patients with hereditary non-polyposis colorectal cancer.

Authors:  P Tannergård; T Liu; A Weger; M Nordenskjöld; A Lindblom
Journal:  Hum Genet       Date:  1997-11       Impact factor: 4.132

3.  BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer.

Authors:  Guoren Deng; Ian Bell; Suzanne Crawley; James Gum; Jonathan P Terdiman; Brian A Allen; Brindusa Truta; Marvin H Sleisenger; Young S Kim
Journal:  Clin Cancer Res       Date:  2004-01-01       Impact factor: 12.531

4.  BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.

Authors:  E Domingo; P Laiho; M Ollikainen; M Pinto; L Wang; A J French; J Westra; T Frebourg; E Espín; M Armengol; R Hamelin; H Yamamoto; R M W Hofstra; R Seruca; A Lindblom; P Peltomäki; S N Thibodeau; L A Aaltonen; S Schwartz
Journal:  J Med Genet       Date:  2004-09       Impact factor: 6.318

5.  Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer.

Authors:  A McGivern; C V A Wynter; V L J Whitehall; T Kambara; K J Spring; M D Walsh; M A Barker; S Arnold; L A Simms; B A Leggett; J Young; J R Jass
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

6.  Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA.

Authors:  C F Taylor; R S Charlton; J Burn; E Sheridan; G R Taylor
Journal:  Hum Mutat       Date:  2003-12       Impact factor: 4.878

7.  Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.

Authors:  J G Herman; A Umar; K Polyak; J R Graff; N Ahuja; J P Issa; S Markowitz; J K Willson; S R Hamilton; K W Kinzler; M F Kane; R D Kolodner; B Vogelstein; T A Kunkel; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

8.  Extensive but hemiallelic methylation of the hMLH1 promoter region in early-onset sporadic colon cancers with microsatellite instability.

Authors:  Yasuyuki Miyakura; Kokichi Sugano; Takayuki Akasu; Teruhiko Yoshida; Masato Maekawa; Soh Saitoh; Hideyuki Sasaki; Tadashi Nomizu; Fumio Konishi; Shin Fujita; Yoshihiro Moriya; Hideo Nagai
Journal:  Clin Gastroenterol Hepatol       Date:  2004-02       Impact factor: 11.382

9.  Germline epimutation of MLH1 in individuals with multiple cancers.

Authors:  Catherine M Suter; David I K Martin; Robyn L Ward
Journal:  Nat Genet       Date:  2004-04-04       Impact factor: 38.330

Review 10.  Hereditary cancer: two hits revisited.

Authors:  A G Knudson
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

View more
  30 in total

Review 1.  Understanding transgenerational epigenetic inheritance via the gametes in mammals.

Authors:  Lucia Daxinger; Emma Whitelaw
Journal:  Nat Rev Genet       Date:  2012-01-31       Impact factor: 53.242

Review 2.  Constitutional epimutation as a mechanism for cancer causality and heritability?

Authors:  Megan P Hitchins
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

Review 3.  Finding the needle in a haystack: identification of cases of Lynch syndrome with MLH1 epimutation.

Authors:  Megan P Hitchins
Journal:  Fam Cancer       Date:  2016-07       Impact factor: 2.375

Review 4.  Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer.

Authors:  Jung Ho Kim; Gyeong Hoon Kang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 5.  Causes and consequences of microsatellite instability in gastric carcinogenesis.

Authors:  Sérgia Velho; Maria Sofia Fernandes; Marina Leite; Ceu Figueiredo; Raquel Seruca
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

Review 6.  Evolution of the cancer genome.

Authors:  Ondrej Podlaha; Markus Riester; Subhajyoti De; Franziska Michor
Journal:  Trends Genet       Date:  2012-02-16       Impact factor: 11.639

7.  Constitutional MLH1 methylation presenting with colonic polyposis syndrome and not Lynch syndrome.

Authors:  Trilokesh D Kidambi; Amie Blanco; Jessica Van Ziffle; Jonathan P Terdiman
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

Review 8.  Epigenetics of colorectal cancer.

Authors:  Ajay Goel; C Richard Boland
Journal:  Gastroenterology       Date:  2012-09-20       Impact factor: 22.682

Review 9.  Familial colorectal cancer type X: genetic profiles and phenotypic features.

Authors:  Mev Dominguez-Valentin; Christina Therkildsen; Sabrina Da Silva; Mef Nilbert
Journal:  Mod Pathol       Date:  2014-04-18       Impact factor: 7.842

10.  Recent discoveries in the molecular genetics of Lynch syndrome.

Authors:  C Richard Boland
Journal:  Fam Cancer       Date:  2016-07       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.